Teladoc Health Inc Stock Price, News & Analysis

Intercept TeleMed has appointed Dr. Richard Boxer, a former Chief Medical Officer of Teladoc, to its senior management team. Boxer's extensive experience in telemedicine and public health will enhance Intercept's mission to provide affordable specialist care to rural hospitals. The company utilizes advanced remote critical care technology and aims to bolster its presence in hospital ICUs across the U.S. This strategic move is seen as vital for improving the quality of care in critical health settings.

Teladoc Health has announced its upcoming Teladoc Health Forum, scheduled for July 20-21, 2021, featuring industry leaders and visionaries as keynote speakers. The event aims to address critical topics in virtual care, including consumer engagement, clinical quality, and chronic condition management. Notable speakers include Andy Slavitt and Leana Wen, among others. The forum will consist of live and on-demand sessions tailored for healthcare executives and organizations, showcasing insights into the rapid growth and innovation within virtual healthcare.

Teladoc Health (NYSE: TDOC) will have its CEO Jason Gorevic and CFO Mala Murthy participate in the William Blair Growth Stock Conference on June 1, 2021, at 1:40 p.m. ET. Investors can access a live audio webcast and replay of the presentation at the company's investor relations website. Teladoc Health is a leader in whole-person virtual care, focusing on transforming healthcare experiences and improving health outcomes through personalized interactions. The company has been recognized as the best in KLAS for Virtual Care Platforms in 2020.

Teladoc Health (TDOC) reported a remarkable 151% revenue growth to $453.7 million for Q1 2021, boosted by a 56% increase in total visits to 3.2 million. The company also tripled the number of consumers enrolled in chronic care programs year-over-year. Despite these gains, it faced a net loss of $199.6 million, largely due to stock-based compensation and amortization from acquisitions. For FY 2021, Teladoc raised its revenue guidance to $1.97 billion - $2.02 billion, maintaining a focus on whole-person care integration.

Teladoc Health (NYSE: TDOC) has appointed Claus Jensen as chief innovation officer to enhance its research and development efforts. Jensen, who has over 20 years of experience in digital transformation at leading healthcare organizations, previously served as chief digital officer at Memorial Sloan Kettering Cancer Center. His expertise includes product innovation, health informatics, and data products. This strategic hire is aimed at accelerating Teladoc's vision of seamless healthcare solutions from hospitals to home, leveraging technology and data insights to improve patient care.

Teladoc Health (NYSE: TDOC) is set to announce its first-quarter 2021 results on April 28, 2021, after market close. The company will host a conference call at 4:30 p.m. E.T. to discuss the results. Interested participants can join by dialing designated numbers or via a live audio webcast accessible online. The recording will be available for approximately 90 days post-call. As a leader in virtual care, Teladoc Health focuses on enhancing health outcomes through innovative, personalized healthcare experiences.

Caption Health has appointed Steve Cashman as the new President and CEO, effective immediately. Cashman previously served as Chief Commercial Officer at InTouch Health, which was acquired by Teladoc (NYSE: TDOC) in 2020. Under his leadership, InTouch achieved a 35% year-over-year growth in 2019. Cashman aims to enhance ultrasound accessibility in healthcare, supported by a $4.95M grant from the Gates Foundation for lung ultrasound AI development. The company has also added new leaders in marketing, finance, and operations, aiming for innovative growth in medical imaging.

Teladoc Health (TDOC) reported a significant growth in Q4 2020, with revenue soaring 145% year-over-year to $383.3 million and total visits rising 139% to 3.0 million. For the full year, revenue grew 98% to $1,094 million, with total visits increasing 156% to 10.6 million. Despite these gains, the net loss for Q4 was $(394.0 million), up from $(19.0 million) in Q4 2019, impacted by acquisition costs and stock-based compensation. Looking ahead, the company provided Q1 2021 revenue guidance of $445 million to $455 million.

Teladoc Health (NYSE: TDOC) announces participation in the Cowen Healthcare Conference on March 2, 2021, featuring CEO Jason Gorevic and CFO Mala Murthy at 12:50 p.m. ET. A live audio webcast and replay will be accessible on their investor relations website.

Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health is a leader in whole-person virtual care, utilizing proprietary health signals to enhance health outcomes. The company focuses on transforming the healthcare experience for improved consumer and professional engagement.